| Literature DB >> 35399986 |
Verhaegen Jeroen1,2, Declercq Jonas1,3, Driesen Ronald1, Timmermans Annick4, Corten Kristoff1,4,5.
Abstract
Background: Total hip replacement (THR) in patients with a history of Legg-Calvé-Perthes disease can be a technically challenging procedure due to the distorted hip morphology. We propose a technique in which THR is preceded by a modified relative femoral neck lengthening (RFNL) procedure. Hereby, we aim to restore the biomechanical parameters.Entities:
Keywords: Arthroplasty; Femur; Hip; Legg-Calve-Perthes disease; Osteotomy; Replacement
Year: 2022 PMID: 35399986 PMCID: PMC8991231 DOI: 10.1016/j.artd.2022.02.008
Source DB: PubMed Journal: Arthroplast Today ISSN: 2352-3441
Figure 1An RFNL of the right hip is shown, posterocranial view. Head of the patient is on the left side. (a) The electrocautery marking at the GT is shown. The thickness of the trochanter fragment should be between 1 and 1.5 cm. The vastus lateralis is peeled off the lateral cortex of the femur and left intact at the vastus ridge (indicated with forceps). A blunt retractor keeps the vastus lateralis elevated. (b) The osteotomy is done with the leg internally rotated. The posterior part of the gluteus medius tendon (indicated with the forceps) is split. (c) The entire anteroposterior capsule is exposed. The trochanter is mobilized anteriorly. The forceps indicates the position of the capsular incision anterosuperiorly, which allows identifying the base of the neck at the greater trochanter. (d) The trochanter mass is mainly bulky in the posterior and cranial directions. The forceps indicates the level of the posterior osteotomy. (e) The posterior osteotomy is done, and the cancellous bone is removed with the nibbler from the posterior inner surface of the posterior cortex. The external rotators remain attached to the posterior cortex. (f) After resection of the superior part of the overhanging trochanter, the base of the neck can be seen (marked with forceps). The surface of the remaining trochanter is reduced posteriorly and superiorly. The posterior capsule is held with the left hand forceps.
Figure 2(a) A 32-year-old male patient with an overhanging and high-riding greater trochanter underwent a modified RFNL followed by a THR. (b) The trochanter is advanced distally in order to have the superior part of the fragment at the same level as the superior neck. This increases the abductor lever arm and allows for an improved access to the femoral canal. Of note is the less optimal screw fixation with convergence at the calcar. (c) A DAA THR is then performed reconstructing leg length and offset.
Figure 3A schematic overview of the radiographic assessment of the biomechanical parameters [23]. First, a line parallel to the interteardrop line is drawn at the tip of the greater trochanter (red). Similarly, a line is drawn at the articular surface (cyan colored), and a line through the center of the femoral head (yellow). The articulotrochanteric distance (ATD) (cyan) is defined as the perpendicular distance between the cyan and red line. A positive ATD means that the articular surface is proximal to the tip of the GT. A negative value means that the articular surface is below the GT. The centro-trochanteric distance (CTD) (yellow) is defined as the distance between the red and yellow line. A positive CTD indicates that the femoral head center is proximal to the tip of the GT. A negative CTD indicates that the center of the femoral head is below the GT. The lateral displacement of the greater trochanter (LDGT) (green) is the horizontal distance from the femoral head center to a vertical line starting at the tip of GT [23].
Demographic and surgical data of the cohort.
| Parameter | Whole cohort (n = 28) | RFNL group (n = 8) | RFNL + THR group (n = 20) | |
|---|---|---|---|---|
| Mean age @ RFNL, y ± SD (range) | 38.1 ± 11.4 (16-58) | 30.8 ± 10.1 (18-48) | 41.0 ± 10.8 (16-58) | .032 |
| Mean age @ THR, y ± SD (range) | 41.8 ± 10.6 (18-59) | - | 41.8 ± 10.6 (18-59) | - |
| Gender | .6 | |||
| Male (n, %) | 10 (35.7) | 3 (37.5) | 7 (35.0) | |
| Female (n, %) | 18 (64.3) | 5 (62.5) | 13 (65.0) | |
| Mean follow-up, y ± SD (range) | 4.0 ± 1.8 (1.9-8.7) | 4.2 ± 2.1 (2.0-6.6) | 3.9 ± 1.8 (1.9 ± 8.7) | .8 |
| Comorbidities | .5 | |||
| Obesity (BMI > 30), n (%) | 2 (7.1) | - | 2 (10.0) | |
| Cerebral palsy | 1 (3.6%) | - | 1 (5.0%) | |
| Ehlers-Danlos | 1 (3.6%) | - | 1 (5.0%) | |
| Achondroplasia | 1 (3.6%) | - | 1 (5.0%) | .5 |
| Previous hip surgery | ||||
| PAO, n (%) | 3 (10.7) | 1 (12.5) | 2 (10.0) | .7 |
| Shelf, n (%) | 3 (10.7) | 1 (12.5) | 2 (10.0) | .7 |
| VDRO, n (%) | 6 (21.4) | 1 (12.5) | 5 (25.0) | .6 |
VDRO, varus derotation osteotomy; PAO, periacetabular osteotomy.
Independent samples t-test.
Fisher’s exact test.
Radiological parameters preoperatively, after relative femoral neck lengthening, and after total hip replacement.
| Parameters | Preoperative | After RFNL | After THR | ||
|---|---|---|---|---|---|
| ATD (mm ± SD) | 1.5 ± 9.7 | 22.8 ± 10.4 | <.001 | - | - |
| CTD (mm ± SD) | −18.7 ± 6.7 | 1.9 ± 9.0 | <.001 | 11.4 ± 10.4 | <0.001 |
| LDGT (mm ± SD) | 34.2 ± 8.1 | 42.4 ± 5.2 | <.001 | 49.9 ± 8.3 | <0.001 |
| LLD | 17.5 ± 10.5 | - | - | 2.7 ± 2.2 | <0.001 |
Leg length difference (LLD; positive value means short in comparison to unaffected side).
Paired samples t-test comparing preoperative values and post-RFNL values.
Paired samples t-test comparing post-RFNL values and post-THR values.
Complications and reoperations for the whole cohort and each subgroup separately.
| Parameter | Whole cohort (n = 28) | RFNL group (n = 8) | RFNL + THR group (n = 20) | |
|---|---|---|---|---|
| Complications grade I | .4 | |||
| Asymptomatic HO, n (%) | 6 (21.4) | 1 (12.5) | 5 (25.0) | |
| Complications grade II | - | - | - | |
| Complications grade III | ||||
| Non-union GT, n (%) | 2 (7.1) | - | 2 (10.0) | |
| Deep infection, n (%) | 1 (3.6) | - | 1 (5.0) | |
| Complications grade IV | - | - | - | |
| Complications grade V | - | - | - | |
| Reoperations | ||||
| Revision RFNL, n (%) | 2 (7.1) | - | 2 (10.0) | .5 |
| Revision THR, n (%) | - | - | 1 (5.0) | - |
HO, heterotopic ossification.
Fisher’s exact test.
Patient-reported outcome measures at the latest follow-up for each subgroup separately.
| RFNL group (n = 6) | RFNL + THR group (n = 18) | ||
|---|---|---|---|
| HHS | 87.7 ± 9.0 | 90.1 ± 11.4 | .4 |
| HOOS symptoms | 77.5 ± 15.7 | 84.7 ± 14.3 | .3 |
| HOOS pain | 80.9 ± 15.1 | 89.6 ± 10.5 | .2 |
| HOOS ADL | 89.5 ± 10.1 | 89.1 ± 12.1 | 1.0 |
| HOOS sports | 69.9 ± 24.3 | 67.3 ± 27.5 | 1.0 |
| HOOS QoL | 60.5 + 18.8 | 71.7 ± 20.3 | .3 |
| Mean SF-36 | 87.6 ± 10.3 | 83.2 ± 15.6 | .5 |
ADL, activities for daily living; QoL, quality of life.
Mann-Whitney U test.